Biological and Pharmaceutical Bulletin
Online ISSN : 1347-5215
Print ISSN : 0918-6158
ISSN-L : 0918-6158
Regular Articles
Chrysin Inhibits Lymphangiogenesis in Vitro
Orawin Prangsaengtong Sirivan AthikomkulchaiJiuxiang XuKeiichi KoizumiAkiko InujimaNaotoshi ShibaharaYutaka ShimadaSarin TadtongSuresh Awale
Author information
JOURNAL FREE ACCESS FULL-TEXT HTML

2016 Volume 39 Issue 4 Pages 466-472

Details
Abstract
The induction of lymphangiogenesis is an important process to promote cancer growth and cancer metastasis via the lymphatic system. Identifying the compounds that can prevent lymphangiogenesis for cancer therapy is urgently required. Chrysin, 5,7-dihydroxyflavone, a natural flavone extracted from Thai propolis, was used to investigate the effect on the lymphangiogenesis process of TR-LE, rat lymphatic endothelial cells. In this study, maximal nontoxic doses of chrysin on TR-LE cells were selected by performing a proliferation assay. The process of lymphangiogenesis in vitro was determined by cord formation assay, adhesion assay and migration assay. Chrysin at a nontoxic dose (25 μM) significantly inhibited cord formation, cell adhesion and migration of TR-LE cells when compared with the control group. We also found that chrysin significantly induced vascular endothelial growth factor C (VEGF-C) mRNA expression and nitric oxide (NO) production in TR-LE cells which was involved in decreasing the cord formation of TR-LE cells. In conclusion, we report for the first time that chrysin inhibited the process of lymphangiogenesis in an in vitro model. This finding may prove to be a natural compound for anti-lymphangiogenesis that could be developed for use in cancer therapy.
Graphical Abstract Fullsize Image
Content from these authors
© 2016 The Pharmaceutical Society of Japan
Previous article Next article
feedback
Top